Know Cancer

or
forgot password

Exercise During Chemotherapy for Patients With Hematological Malignancies


Phase 3
18 Years
70 Years
Open (Enrolling)
Both
Hematological Diseases, Hematological Malignancies

Thank you

Trial Information

Exercise During Chemotherapy for Patients With Hematological Malignancies


Inclusion Criteria:



- Hematological malignant disease

- Current chemotherapy

- Understanding of written German

Exclusion Criteria:

- Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can
be aggravated by exercise

- Pathological stress-ECG at recruitment

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)

Outcome Measure:

Fatigue

Outcome Time Frame:

At recruitment and after 12 weeks

Safety Issue:

No

Principal Investigator

Fernando Dimeo, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Charite University, Berlin, Germany

Authority:

Germany: Ethics Commission

Study ID:

EA4/031/09

NCT ID:

NCT00884364

Start Date:

May 2009

Completion Date:

September 2011

Related Keywords:

  • Hematological Diseases
  • Hematological Malignancies
  • Lymphoma
  • Leukemia
  • Multiple myeloma
  • Hodgkin´s disease
  • Exercise
  • Sport
  • Fatigue
  • Hematological neoplastic diseases
  • Neoplasms
  • Hematologic Diseases
  • Hematologic Neoplasms

Name

Location